| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_07b71571160c289fbf5fc680dfea513f |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-415 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415 |
| filingDate |
2001-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2003-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7410fccdf8ebdd6af9285df95c9aa688
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8290ff949dd6ad9a7143d4b9ca8bd82b |
| publicationDate |
2003-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-6515008-B1 |
| titleOfInvention |
Formulation |
| abstract |
The present invention is directed to a novel pharmaceutical composition of polymorph B which has been found to be stable and palatable for long term commercial usage. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10238640-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008098750-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008098586-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013295188-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004101490-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006062814-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010022588-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10463625-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8937085-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009176884-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AP-2734-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005266031-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10898440-B2 |
| priorityDate |
2000-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |